WHO urges countries to invest more in research to prevent TB transmission

New Delhi: On the eve of the World TB Day, the World Health Organisation on Friday urged the countries to harness the power of technology for early diagnosis of tuberculosis while stressing on more investment into research to prevent its transmission.

WHO regional director for South-east Asia, Dr Poonam Khetrapal Singh, also asked the countries to ensure all persons that have had contact with a TB patient are traced and also screened for the disease.

“Similarly, greater attention should be given to managing latent TB lest it become active, especially for persons living with HIV. Investing in research aimed at developing tools to prevent TB transmission (and that can be applied to large populations) should likewise be prioritized,” Singh said.

She termed the recent region-wide progress as both significant and highly encouraging, and lauded the member countries for increasing their domestic funding for TB programmes with two of them have done so by more than 100 per cent.

“All member countries have accelerated active case-finding. Patient-centered policies have been developed and implemented, including direct cash transfers and nutritional support for persons suffering TB and plans have been developed to engage civil society organizations,” she said.

Maintaining the Region’s leadership, drive and momentum ahead of September’s High-Level Meeting on TB, which will occur alongside the UN General Assembly, is of vital importance, she said while seeking commitment from all levels of society, starting from the highest offices of government to community health workers and volunteers.

  • Related Posts

    NPPA fixes prices of 30 drugs including Vitamin D3, calcium supplements

    The National Pharmaceutical Pricing Authority (NPPA) has fixed the retail prices of 30 drug formulations, including Vitamin D3 oral solution, calcium and vitamin supplements, anti-diabetic medicines, cardiovascular drugs and immunosuppressant…

    Maharashtra FDA seizes ₹73 lakh worth of medicines in crackdown on misleading health claims in ads

    Maharashtra’s Food and Drug Administration has confiscated medicines worth more than ₹73 lakh, including Patanjali-linked products valued at over ₹51 lakh, in a statewide drive against misleading advertisements and misbranded…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    NPPA fixes prices of 30 drugs including Vitamin D3, calcium supplements

    NPPA fixes prices of 30 drugs including Vitamin D3, calcium supplements

    Maharashtra FDA seizes ₹73 lakh worth of medicines in crackdown on misleading health claims in ads

    Maharashtra FDA seizes ₹73 lakh worth of medicines in crackdown on misleading health claims in ads

    Industry asks NPPA to implement SOTS Scheme to resolve pending litigations

    Industry asks NPPA to implement SOTS Scheme to resolve pending litigations

    A Non- Smoker Smoking Hot Spouse needed for Actress Neetu Chandra

    A Non- Smoker Smoking Hot Spouse needed for Actress Neetu Chandra

    Gene Therapy for Cholesterol: Initial Test Results Cheer

    Gene Therapy for Cholesterol: Initial Test Results Cheer

    US Biotech Regeneron to launch Global Capability Centre in Hyderabad

    US Biotech Regeneron to launch Global Capability Centre in Hyderabad